High levels of γ-H2AX foci and cell membrane oxidation in adolescents with type 1 diabetes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 770, Issue , 2014, Pages 128-135

  Giovannini, Caterina ^a   Piaggi, Simona ^a   Federico, Giovanni ^a   Scarpato, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Diabetes; INOS; Peripheral lymphocytes; H2AX

Indexed keywords

HISTONE GAMMA H2AX; HISTONE GAMMA H2AXF; HISTONE H2AX; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; OXYGEN; UNCLASSIFIED DRUG; H2AFX PROTEIN, HUMAN; HISTONE;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL NUCLEUS; CELL STRESS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; FLUORESCENCE ANALYSIS; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE DISORDER; LIPID ANALYSIS; LIPID MEMBRANE; LYMPHOCYTE MEMBRANE; MALE; MALIGNANT NEOPLASTIC DISEASE; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; SEX DIFFERENCE; VALIDITY; CASE CONTROL STUDY; CELL CULTURE; CELL MEMBRANE; DNA DAMAGE; GENETICS; LYMPHOCYTE; METABOLISM; MICRONUCLEUS TEST; OXIDATION REDUCTION REACTION; PHYSIOLOGY; ULTRASTRUCTURE;

ADOLESCENT; CASE-CONTROL STUDIES; CELL MEMBRANE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DNA DAMAGE; FEMALE; HISTONES; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84912032843     PISSN: 00275107     EISSN: 18792871     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2014.08.005     Document Type: Article

References (46)

1. Gordon-Dseagu V.L.Z., Shelton N., Mindell J.S. Epidemiological evidence of a relationship between Type-1 diabetes mellitus and cancer: a review of the existing literature. Int. J. Cancer 2013, 132:501-508.
2. Kaneto H., Kawamori D., Matsuoka T. Oxidative stress and pancreatic beta-cell dysfuction. Am. J. Ther. 2005, 12:529-533.
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
4. Fatmah A.M., Siti B.B., Zariyantey A.H., Nasar A., Jamaludin M. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ. Med. J. 2012, 12:5-18.
5. Maechler P., Jornot L., Wollheim C.B. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J. Biol. Chem. 1999, 274:27905-27913.
6. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 2000, 26:163-176.
7. Gurgul-Convey E., Mehmeti I., Lortz S., Lenzen S. Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria. J. Mol. Med. 2011, 89:785-798.
8. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
9. Rosa J.S., Oliver S.R., Flores R.L., Ngo J., Milne G.L., Zaldivar F.P., Galassetti P.R. Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr. Diabetes 2011, 12:464-472.
10. Woo J., Yeo N.H., Shin K.O., Lee H.-J., Yoo J., Kang S. Antioxidant enzyme activities and DNA damage in children with type 1 diabetes mellitus after 12 weeks of exercise. Acta Paediatr. 2010, 99:1263-1268.
11. Sampson M.J., Winterbone M.S., Hughes J.C., Dozio N., Hughes D.A. Monocyte telomere shortening and oxidative DNA damage in Type 2 diabetes. Diabetes Care 2006, 99:283-289.
12. Ignarro L.J., Degnan J.N., Baricos W.H., Kadowitz P.J., Wolin M.S. Activation of purified guanylate cyclase by nitric oxide requires heme, Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochem. Biophys. Acta 1982, 718:49-59.
13. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci 1994, 17:153-183.
14. Tripathi P. Nitric oxide and immune response. Indian J. Biochem. Biophys. 2007, 44:310-319.
15. Beckman J.S., Koppenol W.H. Nitric oxide and superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996, 271:1424-1437.
16. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.W., Smith T.W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 1996, 184:1425-1433.
17. Hunot S., Boissière F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996, 72:355-363.
18. Wilson K.T., Fu S., Ramanujam K.S., Meltzer S.J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998, 58:2929-2934.
19. Zamora R., Vodovotz Y., Billiar T.R. Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 2000, 6:347-373.
20. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
21. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2000, 106:987-992.
22. Shettigar S.K., Shailaja C., Kulkarni R.K. Elevated micronuclei frequency in type 2 diabetes with high glycosylated hemoglobin. Diabetes Res. Clin. Pract. 2012, 95:246-250.
23. Uziel O., Singer J.A., Danicek V., Sahar G., Berkov E., Luchansky M., Fraser A., Ram R., Lahav M. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp. Gerontol. 2007, 42:971-978.
24. Cinkilic N., Kiyici S., Celikler S., Vatan O., Oz Gul O., Tuncel E., Bilaloglu R. Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in patients with type-1 diabetes mellitus. Mutat. Res. 2009, 676:1-4.
25. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
26. Cucinotta F.A., Pluth J.M., Anderson J.A., Harper J.V., O'Neill P. Biochemical kinetics model of DSB repair and induction of γ-H2AX foci by non-homologous end joining. Radiat. Res. 2008, 169:214-222.
27. Watters G.P., Smart D.J., Harvey J.S., Austin C.A. H2AX phosphorylation as a genotoxicity endpoint. Mutat. Res. 2009, 679:50-58.
28. Scarpato R., Verola C., Fabiani B., Bianchi V., Saggese G., Federico G. Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the γ-H2AX focus assay and micronucleus test. FASEB J. 2011, 25:685-693.
29. Redon C.E., Nakamura A.J., Martin O.A., Parekh P.R., Weyemi U.S., Bonner W.M. Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker. Aging (Albany, NY) 2011, 3:168-174.
30. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
31. American Diabetes Association Standards of medical care in diabetes-2013. Diabetes Care 2013, 36:S11-S66.
32. Scarpato R., Castagna S., Aliotta R., Azzarà A., Ghetti F., Filomeni E., Giovannini C., Pirillo C., Testi S., Lombardi S., Tomei A. Kinetics of nuclear phosphorylation (γ-H2AX) in human lymphocytes treated in vitro with UVB, bleomycin and mitomycin C. Mutagenesis 2013, 28:465-473.
33. Quintana-Lopez L., Blandino-Rosano M., Perez-Arana G., Cebada-Aleu A., Lechuga-Sancho A., Aguilar-Diosdado M., Segundo C. Nitric oxide is a mediator of antiproliferative effects induced by proinflammatory cytokines on pancreatic beta cells. Mediat. Inflamm. 2013, 2013:905175. (10 pages).
34. Ghosh R., Bhattacharya R., Bhattacharya G., Sinha A.K. The Control of stress induced type I diabetes mellitus in humans through the hepatic synthesis of insulin by the stimulation of nitric oxide production. Int. J. Biomed. Sci. 2012, 8:171-182.
35. Yoshida K., Kikutani H. Genetic and immunological basis of autoimmune diabetes in the NOD mouse. Rev. Immunogenet. 2000, 2:140-146.
36. Yang H., Jin X., Wai Kei L.C., Yan S.K. Review: oxidative stress and diabetes mellitus. Clin. Chem. Lab. Med. 2011, 49:1773-1782.
37. Vlassara H., Striker G.E. AGE restriction in diabetes mellitus: a paradigm shift. Nat. Rev. Endocrinol. 2011, 7:526-539.
38. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., Miyazaki J. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 1998, 188:1445-1451.
39. Chen C.C., Lu Y.C., Chen Y.W., Lee W.L., Lu C.H., Chen Y.H., Lee Y.C., Lin S.T., Timms J.F., Lee Y.R., Chou H.C., Chan H.L. Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: role of glucose-induced ROS. J. Proteomics 2012, 75:3760-3777.
40. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002, 106:987-992.
41. Kielstein J.T., Bode-Böger S.M., Frölich J.C., Ritz E., Haller H., Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 2003, 107:1891-1895.
42. Müllner E., Brath H., Toferer D., Adrigan S., Bulla M.T., Stieglmayer R., Wallner M., Marek R., Wagner K.H. Genome damage in peripheral blood lymphocytes of diabetic and non-diabetic individuals after intervention with vegetables and plant oil. Mutagenesis 2013, 28:205-211.
43. Martínez-Pérez L.M., Cerda-Flores R.M., Gallegos-Cabriales E.C., Dávila-Rodríguez M.I., Ibarra-Costilla E., Cortés-Gutiérrez E.I. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med. Rep. 2007, 108:248-255.
44. Hannon-Fletcher M.P., O'Kane M.J., Moles K.W., Weatherup C., Barnett C.R., Barnett Y.A. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat. Res. 2000, 460:53-60.
45. Collins A.R., Raslová K., Somorovská M., Petrovská H., Ondrusová A., Vohnout B., Fábry R., Dusinská M. DNA damage in diabetes: correlation with a clinical marker. Free Radic. Biol. Med. 1998, 25:373-377.
46. Khan S., Raghuram G.V., Bhargava A., Pathak N., Chandra D.H., Jain S.K., Mishra P.K. Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl. Res. 2011, 158:344-359.